scholarly article | Q13442814 |
P2093 | author name string | Edward M Mills | |
Sara M Nowinski | |||
Christine K Dao | |||
P2860 | cites work | Calorigenic effect of glucagon and catecholamines in king penguin chicks | Q71756613 |
Sympathomimetic actions of methylenedioxymethamphetamine in rat and rabbit isolated cardiovascular tissues | Q72117041 | ||
Fatty acid binding site of the mitochondrial uncoupling protein. Demonstration of its existence by EPR spectroscopy of 5-DOXYL-stearic acid | Q72375094 | ||
Isolation of the GDP binding protein from brown adipose tissue mitochondria of several animals and amino acid composition study in rat | Q72939123 | ||
The tissue distribution of the human beta3-adrenoceptor studied using a monoclonal antibody: direct evidence of the beta3-adrenoceptor in human adipose tissue, atrium and skeletal muscle | Q73170902 | ||
Risperidone counteracts lethality in an animal model of the serotonin syndrome | Q73926619 | ||
alpha1-Adrenergic stimulation potentiates the thermogenic action of beta3-adrenoreceptor-generated cAMP in brown fat cells | Q73959904 | ||
Differential diagnosis of thyroid crisis and malignant hyperthermia in an anesthetized porcine model | Q74657893 | ||
THE EFFECTS OF EXERCISE AND LIMITATION OF MOVEMENT ON AMPHETAMINE TOXICITY | Q76553108 | ||
Thyroid hormone and other regulators of uncoupling proteins | Q78148450 | ||
Transport function and regulation of mitochondrial uncoupling proteins 2 and 3 | Q78207921 | ||
Reversal of hypermetabolic brown adipose tissue in F-18 FDG PET imaging | Q82892887 | ||
UCP1 is essential for adaptive adrenergic nonshivering thermogenesis | Q83092333 | ||
The preservation of in vivo phosphorylated and activated uncoupling protein 3 (UCP3) in isolated skeletal muscle mitochondria following administration of 3,4-methylenedioxymethamphetamine (MDMA aka ecstasy) to rats/mice | Q83756823 | ||
Plasma levels of norepinephrine and epinephrine during malignant hyperthermia in susceptible pigs | Q93672806 | ||
Plasma membrane monoamine transporters: structure, regulation and function | Q22251021 | ||
Mice overexpressing human uncoupling protein-3 in skeletal muscle are hyperphagic and lean | Q22254752 | ||
Elevated environmental temperature and methamphetamine neurotoxicity | Q23912102 | ||
UCP3: an uncoupling protein homologue expressed preferentially and abundantly in skeletal muscle and brown adipose tissue | Q24312228 | ||
Identification and importance of brown adipose tissue in adult humans | Q24632425 | ||
Energy metabolism in uncoupling protein 3 gene knockout mice | Q28140746 | ||
Five fatal cases of serotonin syndrome after moclobemide-citalopram or moclobemide-clomipramine overdoses | Q28236980 | ||
Uncoupling protein-3 is a mediator of thermogenesis regulated by thyroid hormone, beta3-adrenergic agonists, and leptin | Q28249563 | ||
Vascular actions of MDMA involve alpha1 and alpha2-adrenoceptors in the anaesthetized rat | Q28365866 | ||
Lack of obesity and normal response to fasting and thyroid hormone in mice lacking uncoupling protein-3 | Q28506464 | ||
Mechanism of fatty-acid-dependent UCP1 uncoupling in brown fat mitochondria | Q28506657 | ||
Regulation of the third member of the uncoupling protein family, UCP3, by cold and thyroid hormone | Q28575898 | ||
Disruption of BCATm in mice leads to increased energy expenditure associated with the activation of a futile protein turnover cycle | Q28593294 | ||
Brown adipose tissue: function and physiological significance | Q29547448 | ||
The structure of the membrane systems in a novel muscle cell modified for heat production | Q30494572 | ||
Sarcolipin is a newly identified regulator of muscle-based thermogenesis in mammals. | Q30540446 | ||
Serotonin syndrome. Presentation of 2 cases and review of the literature | Q33913660 | ||
Uncoupling proteins 2 and 3: potential regulators of mitochondrial energy metabolism. | Q33951526 | ||
Mitochondrial uncoupling as a target for drug development for the treatment of obesity | Q33960204 | ||
The role of monoamines in the changes in body temperature induced by 3,4-methylenedioxymethamphetamine (MDMA, ecstasy) and its derivatives | Q34112933 | ||
Dantrolene in the treatment of MDMA-related hyperpyrexia: a systematic review | Q34140813 | ||
Skin Blood Flow in Adult Human Thermoregulation: How It Works, When It Does Not, and Why | Q34196550 | ||
The pharmacology and clinical pharmacology of 3,4-methylenedioxymethamphetamine (MDMA, "ecstasy"). | Q34215236 | ||
The distribution of brown adipose tissue in the human | Q34228011 | ||
Toxin-induced hyperthermic syndromes | Q34459874 | ||
Thermogenic mechanisms and their hormonal regulation | Q34511697 | ||
Perioperative shivering: physiology and pharmacology | Q34511737 | ||
Stereochemical effects of 3,4-methylenedioxymethamphetamine (MDMA) and related amphetamine derivatives on inhibition of uptake of [3H]monoamines into synaptosomes from different regions of rat brain | Q34559625 | ||
Central neural pathways for thermoregulation. | Q34636440 | ||
Heat acclimation--mechanisms of adaptation to exercise in the heat | Q47726798 | ||
MDMA (ecstasy) inhibition of MAO type A and type B: comparisons with fenfluramine and fluoxetine (Prozac). | Q48099202 | ||
The distribution of 3,4-methylenedioxymethamphetamine "Ecstasy"-induced c-fos expression in rat brain | Q48149811 | ||
Small changes in ambient temperature cause large changes in 3,4-methylenedioxymethamphetamine (MDMA)-induced serotonin neurotoxicity and core body temperature in the rat. | Q48444036 | ||
Central and peripheral mechanisms in the stimulation of adrenocortical secretion by the 5-hydroxytryptamine2 agonist, (+-)-1-(2,5-dimethoxy-4-iodophenyl)-2-aminopropane. | Q51626406 | ||
Ryanodine receptor gene is a candidate for predisposition to malignant hyperthermia. | Q51739604 | ||
Clozapine reverses increased brown adipose tissue thermogenesis induced by 3,4-methylenedioxymethamphetamine and by cold exposure in conscious rats. | Q51915375 | ||
Porcine malignant hyperthermia. VI: the effects of bilateral adrenalectomy and pretreatment with bretylium on the halothane-induced response | Q52706545 | ||
Reduction of FDG uptake in brown adipose tissue in clinical patients by a single dose of propranolol. | Q53504010 | ||
Autoradiographic delineation of skeletal muscle alpha 1-adrenergic receptor distribution. | Q54313372 | ||
Effects of 3,4-methylenedioxymethamphetamine on autonomic thermoregulatory responses of the rat | Q68305346 | ||
Calorigenic effect of adrenaline and noradrenaline in the frog, Rana temporaria | Q68769136 | ||
Pituitary-adrenal axis responses to acute amphetamine in the rat | Q70465842 | ||
Means of noradrenalin action during non-shivering thermogenesis in a single muscle | Q70669888 | ||
Further evidence for a physiological role for hypothalamic dopamine in thermoregulation in the rat | Q71215803 | ||
Isolation of the uncoupling protein from brown adipose tissue mitochondria | Q71238619 | ||
Amphetamine-induced hyperthyroxinemia | Q71540511 | ||
Low environmental temperatures or pharmacologic agents that produce hypothermia decrease methamphetamine neurotoxicity in mice | Q71670584 | ||
Identification of a Mutation in Porcine Ryanodine Receptor Associated with Malignant Hyperthermia | Q34795568 | ||
Thyroid hormone and uncoupling proteins. | Q35130103 | ||
Effects of amphetamines on mitochondrial function: role of free radicals and oxidative stress | Q35153738 | ||
Acute and long-term effects of MDMA on cerebral dopamine biochemistry and function | Q35745285 | ||
Cold but not sympathomimetics activates human brown adipose tissue in vivo | Q36056500 | ||
Carvedilol inhibits the cardiostimulant and thermogenic effects of MDMA in humans. | Q36252777 | ||
Ligand binding properties of putative beta 3-adrenoceptors compared in brown adipose tissue and in skeletal muscle membranes | Q36329762 | ||
Hyperthermic syndromes induced by toxins. | Q36433130 | ||
Dance clubbing on MDMA and during abstinence from Ecstasy/MDMA: prospective neuroendocrine and psychobiological changes | Q36617655 | ||
ROS and Sympathetically Mediated Mitochondria Activation in Brown Adipose Tissue Contribute to Methamphetamine-Induced Hyperthermia | Q36785599 | ||
Mitochondrial respiratory uncoupling promotes keratinocyte differentiation and blocks skin carcinogenesis | Q36944279 | ||
Abnormal nonshivering thermogenesis in mice with inherited defects of fatty acid oxidation | Q37387783 | ||
Human brown adipose tissue | Q37726534 | ||
Physiological importance and control of non-shivering facultative thermogenesis | Q37825305 | ||
Overview of serotonin syndrome | Q38059213 | ||
Diagnosis and treatment of drug-induced hyperthermia | Q38069363 | ||
Synthetic cathinones ("bath salts"). | Q38190773 | ||
Dinitrophenol and obesity: an early twentieth-century regulatory dilemma | Q39213415 | ||
Brown fat and thermogenesis | Q39979072 | ||
The presence of UCP1 demonstrates that metabolically active adipose tissue in the neck of adult humans truly represents brown adipose tissue. | Q39982206 | ||
Thermogenic mechanisms in brown fat | Q40140016 | ||
3,4-Methylenedioxymethamphetamine induces a hyperthermic and hypermetabolic crisis in pigs with and without a genetic disposition for malignant hyperthermia | Q40268773 | ||
Effect of peripheral noradrenaline on thermoregulation in temperature-acclimated pigeon | Q40347418 | ||
Influence of dietary fats on Ecstasy-induced hyperthermia | Q40448851 | ||
Does hyperthyroidism increase risk of death due to the ingestion of ecstasy? | Q40449090 | ||
Carvedilol reverses hyperthermia and attenuates rhabdomyolysis induced by 3,4-methylenedioxymethamphetamine (MDMA, Ecstasy) in an animal model | Q40506688 | ||
Strenuous exercise aggravates MDMA-induced skeletal muscle damage in mice. | Q40519340 | ||
Pharmacology: uncoupling the agony from ecstasy | Q40544943 | ||
Hypothalamic-pituitary-thyroid axis and sympathetic nervous system involvement in hyperthermia induced by 3,4-methylenedioxymethamphetamine (Ecstasy). | Q40563105 | ||
Diazepam and chlormethiazole attenuate the development of hyperthermia in an animal model of the serotonin syndrome | Q40564220 | ||
Cutaneous vasoconstriction contributes to hyperthermia induced by 3,4-methylenedioxymethamphetamine (ecstasy) in conscious rabbits. | Q40594777 | ||
Drug-induced hyperthermia | Q40645990 | ||
CNS regulation of thermogenesis. | Q40707158 | ||
Hyperthermia associated with drug intoxication. | Q40803720 | ||
Environmental and drug-induced hyperthermia. Pathophysiology, recognition, and management | Q40825462 | ||
Fever versus hyperthermia | Q40870730 | ||
Pharmacological and clinical studies of ephedrine and other thermogenic agonists | Q41026233 | ||
Thyroid hormone control of thermogenesis and energy balance | Q41113110 | ||
Ephedrine-induced thermogenesis in man: no role for interscapular brown adipose tissue. | Q41592879 | ||
Cold tolerance of UCP1-ablated mice: a skeletal muscle mitochondria switch toward lipid oxidation with marked UCP3 up-regulation not associated with increased basal, fatty acid- or ROS-induced uncoupling or enhanced GDP effects | Q42468653 | ||
Thermogenic responses in brown fat cells are fully UCP1-dependent. UCP2 or UCP3 do not substitute for UCP1 in adrenergically or fatty scid-induced thermogenesis | Q42488444 | ||
Analysis of inhibition by H89 of UCP1 gene expression and thermogenesis indicates protein kinase A mediation of beta(3)-adrenergic signalling rather than beta(3)-adrenoceptor antagonism by H89. | Q43597361 | ||
Presence of alpha-1 adrenoreceptors on thermosensitive neurons in the medial preoptico-anterior hypothalamic area in rats. | Q43977406 | ||
Plasma concentrations of 5-HT, 5-HIAA, norepinephrine, epinephrine and dopamine in ecstasy users. | Q44038887 | ||
Actions of amphetamine derivatives and cathinone at the noradrenaline transporter | Q44582033 | ||
Induction of Malignant Hyperthermia in Susceptible Swine by 3,4-Methylenedioxymethamphetamine (“Ecstasy”) | Q44630646 | ||
The role of sympathetic activity in initiating malignant hyperthermia | Q44686206 | ||
Dantrolene use in 3,4-methylenedioxymethamphetamine (ecstasy)-mediated hyperthermia | Q44954377 | ||
UCP3 and thyroid hormone involvement in methamphetamine-induced hyperthermia | Q45042241 | ||
Uncoupling protein-3 as a molecular determinant of the action of 3,5,3'-triiodothyronine on energy metabolism. | Q45929763 | ||
3,4-Methylenedioxymethamphetamine (ecstasy) activates skeletal muscle nicotinic acetylcholine receptors | Q46537658 | ||
P433 | issue | 3 | |
P304 | page(s) | 183-191 | |
P577 | publication date | 2014-10-01 | |
P1433 | published in | Temperature : multidisciplinary biomedical journal | Q26854026 |
P1476 | title | The heat is on: Molecular mechanisms of drug-induced hyperthermia | |
P478 | volume | 1 |
Q37458263 | Clinically Relevant Pharmacological Strategies That Reverse MDMA-Induced Brain Hyperthermia Potentiated by Social Interaction. |
Q90749493 | Hepatic Metabolic Derangements Triggered by Hyperthermia: An In Vitro Metabolomic Study |
Q55210356 | Interactions of Gut Microbiota, Endotoxemia, Immune Function, and Diet in Exertional Heatstroke. |
Q39345691 | MDMA, Methylone, and MDPV: Drug-Induced Brain Hyperthermia and Its Modulation by Activity State and Environment |
Q37543977 | Potentiation of Ecstasy-induced hyperthermia and FAT/CD36 expression in chronically exercised animals |
Q60309752 | Sympathomimetic amine compounds and hepatotoxicity: Not all are alike-Key distinctions noted in a short review |
Q36832628 | Temperature in the spotlight of drug abuse research |
Q26740509 | The pathophysiological basis and consequences of fever |
Search more.